Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A agammaglobulinemia that is part of a larger syndrome.
Biomarker and diagnostic research for syndromic agammaglobulinemia has been reported in the published literature.
8 clinical trials registered, 7 recruiting. Interventions under study include drug therapy, other interventions, and biologic therapy. Pipeline includes 3 PHASE3, 2 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT07220915](https://clinicaltrials.gov/study/NCT07220915) |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:55 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
PHASE3 |
Octapharma |
RECRUITING |
[NCT05645107](https://clinicaltrials.gov/study/NCT05645107) | A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma | PHASE3 | Grifols Therapeutics LLC | RECRUITING |
[NCT05678621](https://clinicaltrials.gov/study/NCT05678621) | Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension | PHASE2 | Monash University | RECRUITING |
[NCT06976476](https://clinicaltrials.gov/study/NCT06976476) | Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia | PHASE2 | Memorial Sloan Kettering Cancer Center | RECRUITING |
[NCT05321407](https://clinicaltrials.gov/study/NCT05321407) | COVID-19 Vaccine Responses in PIDD Subjects | — | Duke University | ACTIVE_NOT_RECRUITING |
225 publications have been identified in PubMed for syndromic agammaglobulinemia. Kisho has analyzed 120 by research type. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (30%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 40 | 33% |
Patient case studies | 36 | 30% |
Disease patterns and progression | 20 | 17% |
Clinical study results | 8 | 7% |
Laboratory research | 8 | 7% |
Testing and diagnosis research | 5 | 4% |
Other research | 2 | 2% |
New treatment approaches | 1 | 1% |
Lewandrowski C (2026). [PMID: 41451820](https://pubmed.ncbi.nlm.nih.gov/41451820/). *Curr Opin Allergy Clin Immunol*. [Review / Meta-Analysis]
Consolini R (2026). [PMID: 42123030](https://pubmed.ncbi.nlm.nih.gov/42123030/). *J Clin Med*. [Review / Meta-Analysis]
Justiz Vaillant AA (2026). [PMID: 29763203](https://pubmed.ncbi.nlm.nih.gov/29763203/). *Unknown Journal*. [Review / Meta-Analysis]
Azuma Y (2026). [PMID: 41793776](https://pubmed.ncbi.nlm.nih.gov/41793776/). *Immunol Med*. [Case Report / Case Series]
Marakhonov A (2026). [PMID: 41727503](https://pubmed.ncbi.nlm.nih.gov/41727503/). *Front Immunol*. [Diagnostic / Biomarker]
Ahmadinia M (2026). [PMID: 41689663](https://pubmed.ncbi.nlm.nih.gov/41689663/). *Clin Exp Med*. [Review / Meta-Analysis]
Soomann M (2026). [PMID: 41177434](https://pubmed.ncbi.nlm.nih.gov/41177434/). *J Allergy Clin Immunol Pract*. [Diagnostic / Biomarker]
Chung J (2026). [PMID: 41843217](https://pubmed.ncbi.nlm.nih.gov/41843217/). *Eur J Pediatr*. [Review / Meta-Analysis]
Killeen RB (2026). [PMID: 30855793](https://pubmed.ncbi.nlm.nih.gov/30855793/). *Unknown Journal*. [Basic Science / Preclinical]
Jain JB (2026). [PMID: 34283424](https://pubmed.ncbi.nlm.nih.gov/34283424/). *Unknown Journal*. [Basic Science / Preclinical]